HyperLink

Home      About     Contact Us    Make this your homepage   
Conferences
Recruitment NEW
Training Courses
Market Tutorials
Market Reports
Custom Analysis
Audio CDs
Past Conferences
Personalized Medicine Market Report 2007



Published: April 2007
Pages: 104

Pricing
Electronic Site License

€2,950.00 Buy now >>

Single User Print Version

€2,500.00 Buy now >>

Table of Contents

This report presents the latest industry analysis of the emerging field of Personalized Medicine. There is increasing interest in this field driven by the development of a number of molecular diagnostics-based tests that determine a patient’s genetic predisposition to a given disease—such as cancer, or to adverse drug reactions (ADRs).

Personalized Medicine is growing rapidly—this report documents the various tests currently available, their market opportunity and hurdles to their market adoption. In addition, Select Biosciences presents in this report the current pipeline of personalized medicine-based tests in various different therapeutic areas.

This report is the only report on the marketplace that presents a market analysis of the personalized medicine space based upon a proprietary market survey performed recently by Select Biosciences. The market analysis addresses qualitative market trends and quantitative market metrics, and pinpoints the opportunities and hurdles in this market.  


For more details about the market metrics presented in this report or the industry coverage presented in this report, please e-mail kgray@selectbiosciences.com.

Topics Covered in this Report
  • The Personalized Medicine Space
  • Market Drivers
  • CYP450 Polymorphisms and Drug Metabolism
  • Personalized Medicine-based Tests on the Market Today
  • Pipeline of Personalized Medicine-based Tests
  • Regulatory Guidelines in the Personalized Medicine Space
  • The Molecular Diagnostics Marketplace: Quantitative Metrics, Emerging Applications, and Market Trends—Personalized Medicine is a Fast-Growing Segment of Molecular Diagnostics
  • Personalized Medicine Market Analysis: Qualitative and Quantitative Market Metrics based on Market Survey Data
  • Company Profiles: Of the Relevant Market Participants


  • Companies Profiled in this Report
  • Abbott Molecular/Vysis
  • Affymetrix
  • Agendia
  • Celera Diagnostics
  • Cepheid
  • Clinical Data: PGxHealth and Cogenics
  • Dakocytomation
  • decode Genetics
  • DNA Direct
  • DxS Ltd
  • Exact Sciences
  • Exagen Diagnostics
  • Gen-Probe
  • Genelex
  • Gene Logic
  • Genentech
  • Genomic Health, Inc.
  • Genzyme Genetics
  • Illumina
  • Luminex/Tm Biosciences
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen
  • Osmetech plc
  • Perlegen Sciences
  • PGxI Laboratories
  • Prometheus Laboratories
  • Roche Diagnostics
  • Siemens Medical Solutions Diagnostics
  • Target Discovery
  • Third Wave Technologies
  • XDx
  • Ventana Medical Systems


  • Purchase report >>

     

    © SelectBiosciences 2007